Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR2 | Q9NS75 | 9/20 | 0.55 |
| ▸ | CYSLTR1 | Q9Y271 | 9/20 | 0.55 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9509072 | 0.90 | CYSLTR2 (0.54) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9508064 | 0.85 | CYSLTR2 (0.53) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9579635 | 0.81 | CYSLTR2 (0.51) | CYSLTR2CYSLTR1GRM2LMNAPPARG | |
| SCHEMBL9506662 | 0.81 | CYSLTR2 (0.53) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9509156 | 0.81 | CYSLTR2 (0.52) | CYSLTR2CYSLTR1GRM2LMNACYP1A2 | |
| SCHEMBL9508793 | 0.80 | GRM2 (0.57) | CYSLTR2CYSLTR1GRM2LMNACYP1A2 | |
| SCHEMBL9510563 | 0.80 | GRM2 (0.57) | CYSLTR2CYSLTR1GRM2LMNACYP1A2 | |
| SCHEMBL9510539 | 0.79 | CYSLTR2 (0.56) | CYSLTR2CYSLTR1GRM2LMNACYP1A2 | |
| SCHEMBL9510405 | 0.79 | GRM2 (0.56) | CYSLTR2CYSLTR1GRM2 | |
| SCHEMBL9509087 | 0.79 | CYSLTR2 (0.53) | CYSLTR2CYSLTR1GRM2LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0310126-B1 | DERIVATIVES OF PYROCATECHOL-CARBOXYLIC ACID, THEIR PREPARATION AND USE AS ACTIVE INGREDIENTS IN MEDICINES | F. HOFFMANN-LA ROCHE AG (CH) | 1993-08-18 | — | — | EP | claimed |
| EP-0310126-B1 | DERIVATIVES OF PYROCATECHOL-CARBOXYLIC ACID, THEIR PREPARATION AND USE AS ACTIVE INGREDIENTS IN MEDICINES | F. HOFFMANN-LA ROCHE AG (CH) | 1993-08-18 | — | — | EP | disclosed |
| US-5191108-A | Lipoxygenase inhibitors, antiinflammatory agents | HOFFMANN-LA ROCHE INC. (US) | 1993-03-02 | — | — | US | disclosed |
| US-5025036-A | Antiinflammatory agents, gastrointestinal, cardiovascular and skin disorders | HOFFMANN-LA ROCHE INC. (US) | 1991-06-18 | — | — | US | disclosed |
| EP-0310126-A2 | Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines | F. HOFFMANN-LA ROCHE AG (CH) | 1989-04-05 | — | — | EP | disclosed |